Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,766 public trials 495 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Active, Not Recruiting

A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

NCT03611868

Conditions
Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +33 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Highlands Oncology Rogers, Arkansas, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
  • Sarcoma Oncology Research Center Santa Monica, California, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib

NCT03235245

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations
  • University Hospitals Copenhagen - Herlev Hospital - University Copenhagen Herlev, Denmark
  • Odense University Hospital Odense, Denmark
  • Helsinki University Central Hospital - Dept of Oncology Helsinki, Finland
  • Tampere University Hospital Tampere, Finland
View all 38 locations
View Trial Details
Active, Not Recruiting

A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 Inhibition

NCT05061134

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Sacramento, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Tampa, Florida, United States
View all 66 locations
View Trial Details
Active, Not Recruiting

Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma

NCT05315258

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +16 more
Locations
  • Cambridge University Hospitals NHS Foundation Trust (Screening only) Cambridge, United Kingdom
  • The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • The Clatterbridge Cancer Centre Liverpool, United Kingdom
  • University College London Hospital London, United Kingdom
View Trial Details
Active, Not Recruiting

Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin

NCT06640530

Conditions
Advanced Melanoma, Melanoma, Melanoma (Skin), +11 more
Locations
  • Healthcare Institution "Brest Regional Oncological Dispensary" Brest, Belarus
  • Health Institution "Gomel Regional Clinical Oncology Center" Homyel, Belarus
  • Healthcare Institution "Minsk City Clinical Cancer Center" Minsk, Belarus
  • State Institution "Republic Scientific and Practical Centre for Oncology and Medical Radiology Named after N.N.Aleksandrov" Minsk, Belarus
View all 44 locations
View Trial Details

Related conditions